The Veterinary Practice Purchase Agreement in 2026: Reps, Warranties, and Indemnification

Key takeaways

• The veterinary practice purchase agreement is where the real deal lives. It is the 50 to 80 page binding contract that follows the largely non-binding letter of intent, usually structured as an asset purchase, and nearly every word of it is enforceable.
• You will make 25 to 40 representations and warranties; the buyer makes about 5. The asymmetry is normal, but each seller rep is a promise you are standing behind, backed by indemnification if it proves false.
• Indemnification is bounded by a basket and a cap. The basket is the loss threshold a buyer must clear before claiming; the cap is the ceiling on your liability, with fraud and fundamental reps usually falling outside it.
• A holdback of 10 to 15 percent of the price is common in vet deals, and a working-capital adjustment trues the price up or down 60 to 90 days after closing, so the final figure is not known on closing day.
• This is information, not legal advice. The purchase agreement is where deals are won and lost on terms, not just price, and it is exactly the document you want experienced deal counsel and an advisor reading line by line.

The hardest conversation I have with an owner almost never happens at the headline number. It happens later, weeks after the offer everyone celebrated, when a thick contract lands in their inbox and the air goes out of the room.

One vet called me on a Sunday after his attorney sent the first markup. “I thought we agreed on the price,” he said. “Why is this 70 pages, and why does it say I’m personally promising 30 different things?”

That moment is the one I want to take you through here. The price you negotiate is real, but it isn’t the deal.

The deal is the veterinary practice purchase agreement, the binding contract that turns the handshake into something enforceable. And the terms buried inside it, the reps, the indemnification, the holdback, the survival period, often move more after-tax money than the last turn of price negotiation ever did.

Here’s the part owners get backwards. They spend months agonizing over the multiple, then treat the purchase agreement like paperwork to be signed once the lawyers are done.

It is the opposite. This is the single document where you are most exposed and least equipped, sitting across from a buyer’s deal team that has done this a hundred times.

Reading it well is how you keep the number you fought for.

The veterinary practice purchase agreement is the legally binding contract that governs your sale, signed after the letter of intent and usually structured as an Asset Purchase Agreement, often running 50 to 80 pages of dense legal text. It defines exactly which assets transfer, the price and how it is paid, the representations and warranties you make, how the buyer is made whole if one proves false, and what you can and cannot do after closing.

This is the late-stage cousin of the letter of intent; the LOI is the non-binding term sheet, and this is the binding contract that follows it. None of what follows is legal advice.

It is the map I wish every owner had before they opened that 70-page document for the first time.

Where the purchase agreement sits in the sale

By the time the purchase agreement shows up, you have already done the hard emotional work. You decided to sell, you ran a process, you signed a letter of intent.

The agreement is the back half of the deal, and understanding the sequence keeps it from feeling like an ambush.

A practice sale is a long road. Deal prep typically begins 12 to 18 months before listing, and the full transaction usually takes 6 to 12 months from the start of marketing to closing, per the veterinary M&A firm DMcounsel.

We map that full timeline in our guide to how long it takes to sell. The purchase agreement lands in the final stretch of that road, after due diligence is well underway.

It follows the LOI, and the difference between the two documents matters more than almost anything else here.

How the purchase agreement differs from the LOI

The letter of intent and the purchase agreement are not two versions of the same thing. One is a sketch.

The other is the building.

The letter of intent is short, and almost all of it is non-binding. The veterinary practice law firm Mahan Law notes that the LOI’s one truly binding clause is usually the exclusivity or no-shop provision, the 60 to 90 day window in which you agree not to shop the practice to anyone else.

Everything else in the LOI, the price, the structure, the broad strokes, is a statement of intent that the parties still have to paper into a real contract.

The purchase agreement is that real contract. It is long, detailed, and binding in nearly every clause.

It is where the price becomes an enforceable obligation, where the assets are listed by name, and where your post-closing promises get teeth.

Dimension	Letter of intent (LOI)	Purchase agreement (APA)
Length	A few pages	Commonly 50 to 80 pages
Binding?	Mostly non-binding; usually only exclusivity binds	Binding in nearly every clause
What it sets	Headline price, structure, broad terms	The full legal mechanics that transfer the practice
Reps and warranties	None, or minimal	The seller’s 25 to 40 reps live here
Indemnification, holdback, covenants	Not yet	Fully detailed and enforceable
When it’s signed	Before due diligence	After due diligence, near closing

If the LOI says what the deal is in principle, the purchase agreement is the deal. That is why a strong LOI matters so much.

Terms you let drift in the LOI tend to harden against you by the time they reach the binding document.

Why most veterinary sales are asset purchases

Almost every vet practice sale I see is structured one specific way, and it shapes the entire agreement. It is an asset purchase, not a stock purchase.

In an asset purchase, the buyer acquires specific named assets of the practice rather than buying the legal entity itself. The Asset Purchase Agreement, or APA, is the cornerstone document that defines exactly what transfers, per DMcounsel.

This is the structure buyers prefer, because it lets them choose what they take and leave behind liabilities they didn’t sign up for.

What that means in practice is that some things you might assume go with the practice actually stay with you. Mahan Law’s breakdown of assumed assets and liabilities lists accounts receivable, cash and bank accounts, your ownership shares, real property, and any license that has to be held by a licensed professional, such as a DEA registration that cannot be auto-transferred, as items typically excluded from the transferred assets.

Pre-closing operational liabilities and litigation generally stay with the seller too.

This is one reason an asset sale changes the tax math and the real estate conversation. We cover the tax consequences of selling and the separate question of selling the real estate in their own pieces, because both get decided inside or alongside this agreement.

Representations and warranties: the promises you make

Now to the clause that rattled the vet who called me on a Sunday. The representations and warranties are the heart of the seller’s exposure, and the place owners are most surprised by what they are signing.

Representations and warranties are factual statements each party makes in the agreement and stands behind. They cover the things a buyer is relying on but can’t fully verify on their own: that your financial statements are accurate, that you are in legal and licensing compliance, that there is no undisclosed litigation, that your client relationships are what you say they are.

The asymmetry is the part that stings. In a typical middle-market deal, the seller or target makes roughly 25 to 40 representations and warranties, while the buyer makes only about 5, per the M&A advisory resource Acquisition Stars.

That is not a sign anyone is trying to take advantage of you. It is structural.

You know the practice; the buyer is taking your word for it, so you carry the burden of standing behind the facts.

Each rep is a promise with a consequence. If one proves false after closing, the buyer doesn’t just shrug.

They have a remedy, and that remedy is indemnification.

Indemnification: what happens when a rep proves false

Indemnification is the engine that gives the reps their force. Understand it, and the whole agreement starts to make sense.

Indemnification is the provision that reimburses a party for losses caused by the other party’s breach of a rep, warranty, or covenant. The National Law Review describes it plainly: it makes the buyer financially whole after a seller breach, and it is effectively a prerequisite for any buyer to sign.

No buyer hands over millions of dollars without a way to claw some back if a core promise turns out to be wrong.

But indemnification is not unlimited, and the two clauses that bound it are where a good advisor earns their keep. They are the basket and the cap.

The basket is a threshold of losses the buyer must exceed before they can claim indemnification at all. The cap is a ceiling on the total amount the seller can be liable for.

Together they keep small, inevitable post-closing hiccups from turning into claims, and they protect you from open-ended exposure.

Here is roughly how those land in the broader market. In the ABA’s 2025 Private Target Deal Points Study, most deals with survival provisions had a basket, with 67 percent structured as a deductible, and 95 percent of those baskets were 1 percent or less of transaction value, including 45 percent at 0.5 percent or less.

On the cap side, the firm Wyrick Robbins reports that the median cap for general reps in reported transactions is approximately 10 percent of total transaction value, and that over half of all reported deals have caps of 10 percent or less.

One critical carve-out. Fraud and the fundamental reps, things like clear title and authority to sell, usually fall outside the cap.

The bright line is worth remembering: the cap protects you from honest mistakes, not from misrepresentation.

Indemnification term	Plain meaning	What the broader market shows
Basket	Loss threshold the buyer must exceed before claiming	Present in most deals; 67% structured as a deductible; usually 1% or less of deal value (ABA 2025)
Cap	Ceiling on total seller liability	Median around 10% of transaction value for general reps; over half of deals capped at 10% or less (Wyrick Robbins)
Survival period	Window in which a claim can be brought	Commonly 12 to 24 months for general reps; median returned to 12 months (SRS Acquiom 2025)
Carve-outs	Items outside the cap	Fraud and fundamental reps (title, authority, taxes) typically uncapped

A quick note on scale. Those ABA and SRS figures come from middle-market deals, generally larger than most single veterinary practices, so treat them as directional benchmarks rather than precise predictions for your deal.

The structure, basket then cap then carve-outs, is the same at every size. The exact percentages are negotiated.

The survival period: how long your promises last

A rep doesn’t last forever, and the length of time it does last is one of the most negotiated numbers in the agreement. It is called the survival period.

The survival period is the window after closing during which a buyer can still bring an indemnification claim for a breached representation. Once it lapses, the door closes on that category of claim.

General, non-fundamental reps commonly survive 12 to 24 months after closing, and the SRS Acquiom 2025 M&A Deal Terms Study found the median survival period returned to 12 months. The fundamental reps and fraud survive much longer, often for years or the full statute of limitations, which is exactly why they sit outside the cap.

The logic holds together: the most serious promises last the longest and carry the most exposure.

Shorter survival is better for a seller, because it ends your tail of liability sooner and frees up whatever the buyer is holding back. This is one of the cleanest examples of a term that never shows up in the headline price but directly affects when, and how much of, your money is truly yours.

The holdback and the working-capital adjustment

Two mechanics decide how much of your price actually hits your account on closing day, and how much arrives later. Owners are often startled that the full number isn’t wired at the table.

This is why.

The first is the holdback. An indemnification holdback is a portion of the purchase price the buyer holds back at closing and pays later, instead of paying it in full to the seller.

Mahan Law reports that in veterinary practice sales the holdback typically runs 10 to 15 percent of the total purchase price, securing seller breaches of reps and warranties, working-capital true-ups, identified known risks, and earn-outs. It is the buyer’s pool of recourse if something goes wrong, and the balance is released to you as the survival period winds down if no covered claim arises.

This is common, not a red flag. In the broader market the picture is actually splitting in two.

The ABA 2025 study found that dedicated indemnification holdbacks have fallen to 38 percent of deals, down from 60 percent, as reps and warranties insurance absorbs that risk in larger transactions. In smaller, traditional deals like most veterinary practice sales, though, a straightforward seller holdback remains the standard tool, which is why the 10 to 15 percent vet-deal range still holds.

The second mechanic is the working-capital adjustment, and it is the one most likely to surprise an owner after closing. A working-capital adjustment trues up the price to an agreed net-working-capital peg, a normalized average target set during financial due diligence.

Prairie Capital Advisors explains the mechanic clearly: if actual working capital at closing exceeds the peg, the buyer pays the seller the surplus; if it falls short, the seller pays, or it is drawn from the holdback.

The catch is timing. That true-up is typically performed 60 to 90 days after close, so the final dollar figure is not known on closing day.

The peg gets set during due diligence, which is one more reason the diligence phase and the agreement are joined at the hip, and one more reason to have someone on your side of the table who reads the peg definition as carefully as the buyer’s team wrote it.

Reps and warranties insurance: the shift reshaping deals in 2026

There is a quiet structural change happening in how risk gets allocated in these agreements, and it is worth understanding even if your own deal never uses it. It is reps and warranties insurance.

Reps and warranties insurance (RWI) is a policy that shifts the risk of a rep breach from the seller to an insurer, so the buyer claims against the policy instead of clawing back from the seller. It has become near-standard in larger middle-market and sponsor-backed deals.

The ABA 2025 study found that 63 percent of deals referenced RWI, up from 55 percent in 2023, and that deals where the reps do not survive closing at all rose to 41 percent, from 30 percent, driven largely by RWI shifting the risk to insurers.

For a seller, that can be a genuinely better outcome. If the insurer carries the risk, your survival tail can shrink toward zero and more of your money stays yours sooner.

Pricing has moved, though. The law firm Ice Miller reports that average quoted RWI rates rose from about 2.5 percent of the coverage limit in late 2024 to roughly 3.23 percent in late 2025, with healthcare among the sectors drawing the highest retentions because of underwriting complexity.

Carriers now actively participate in diligence and negotiate policy carve-backs.

The honest caveat for most vet owners: RWI is far more common in larger deals, and many smaller practice sales still run on a traditional seller indemnity and holdback. Whether it fits your deal depends on size, buyer type, and process, and it is one of the levers worth modeling early rather than discovering late.

Covenants and the non-compete after the FTC reversal

The agreement doesn’t just govern the sale. It governs what you do after, through a set of restrictive covenants, and a recent regulatory swing has created real confusion here that I want to clear up.

Restrictive covenants are the seller’s binding post-closing obligations, per Mahan Law, typically a non-compete that bars you from opening a new vet practice within a set time and geographic radius, plus non-solicitation of the practice’s clients and employees. Your reps also survive, so the buyer keeps legal remedies if a representation proves false after closing.

These covenants protect the goodwill the buyer just paid for, and most of your sale price is goodwill.

Now the part that confuses owners. The FTC’s 2024 rule banning most non-competes never took effect; a court blocked it in August 2024, and the AVMA reports the FTC voted 3 to 1 in September 2025 to formally vacate it, returning enforceability to state law on a case-by-case basis.

Critically, the sale-of-business exception always remained intact.

So here is the plain answer. A buyer can still require you, as a selling veterinary owner, to sign a non-compete and non-solicitation as part of the deal.

State law governs the scope and duration, and a handful of states, including California, Minnesota, North Dakota, and Oklahoma, broadly limit employee non-competes, which is exactly why this belongs with deal counsel licensed in your state rather than a national rule of thumb.

A brief related note on deal structure. Earn-outs, part of the price paid later only if the practice hits agreed targets, are actually declining in the broader market; the ABA 2025 study found earn-out use fell to 18 percent, from 26 percent in 2023.

Vet practice deals more often bridge any valuation gap with holdbacks or minimum-revenue guarantees instead.

Why the agreement rewards the side that prepared

Step back and a pattern emerges that explains why I push owners so hard on this document. The purchase agreement is a contest of preparation, and the buyer’s deal team prepares for a living.

They draft the first version. They set the basket, the cap, the survival period, the holdback size, the peg definition, the covenant radius, all in the language most favorable to them.

Every one of those terms is negotiable, and every one of them moves real money. An owner reading it alone, for the first time, against a team that has papered dozens of these, is not in a fair fight.

This is where running a real process pays off twice. The Elite Selling System is how we create that leverage, hand-selecting and vetting every buyer who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people, then running a private competitive window inside that vetted group.

Competition doesn’t just lift the price. It improves the terms, because a buyer who knows another qualified bidder is waiting negotiates the basket, the cap, and the survival period far more reasonably.

The choice of who you sell to shapes the agreement too. A PE-backed group, an independent buyer, or a strategic acquirer like Mars each bring different standard terms to the table, and thinking through who to sell to early lets you anticipate the agreement instead of reacting to it.

None of these buyer types is the enemy. They are the bidders your competitive process is built to bring to the table on terms that favor you.

What this means for your practice

The purchase agreement is where a good sale is protected and a careless one is quietly diminished. The price gets the attention.

The terms get the money.

Three things decide most of your real outcome inside this document. How exposed your reps and indemnification leave you, which the basket, cap, and survival period control.

How much of your price is held back or trued up later, which the holdback and working-capital adjustment control. And what you are bound to do after closing, which the covenants control.

Not one of those is something to meet for the first time in a buyer’s first draft.

You want to meet them in your own preparation, with an advisor who has read hundreds of these and deal counsel licensed in your state. We connect this work to the broader picture in our guide to selling a veterinary practice, the owner’s decision guide to the whole sale, and how advisory representation works in our broker and advisor guide.

What to do next

If you take one thing from all of this, take this. The headline number is a starting point, and the purchase agreement is where that number either holds or leaks.

The owners who keep the most are the ones who understood the document before it arrived.

The most useful first step is knowing what your practice is actually worth and how a sale would likely be structured, because the value and the structure shape every term in the agreement that follows. That clarity is what lets you read the first draft as a participant, not a passenger.

Get a Free Practice Value Estimate →

We pull your numbers ourselves, build a defensible normalized EBITDA, and show you what a realistic deal would look like, including the structure and the terms you would be negotiating inside the purchase agreement. Then, when you’re ready, we run a competitive process that lifts both the price and the terms, and we sit on your side of the table alongside your deal counsel through the entire agreement.

The estimate is free and there’s no obligation to engage further. The Transitions Elite engagement model is success-based, with no upfront fees and no retainer, so we only get paid when a deal closes and only out of the value our process delivers.

This article is general information, not legal or tax advice. Every purchase agreement is specific to its deal, its state, and its parties, and you should have it reviewed by qualified deal counsel before you sign.

---

Further reading

These are the related TE resources I’d point any vet toward as they move from offer to closing. Each goes deep on one piece of the picture.

• Veterinary practice letter of intent — the non-binding term sheet that comes before this binding agreement.
• Veterinary practice due diligence — the verification phase where the working-capital peg and many reps get set.
• How long it takes to sell a veterinary practice — where the agreement sits in the full timeline.
• Veterinary practice goodwill — the value the covenants are written to protect.
• Tax consequences of selling a veterinary practice — the tax picture an asset sale creates.
• Veterinary practice exit strategy — planning the whole exit, of which the agreement is the final document.

Frequently asked questions

What is a veterinary practice purchase agreement?

A veterinary practice purchase agreement is the legally binding contract that governs the sale, signed after the non-binding letter of intent. Most veterinary sales are structured as asset purchases, so it is usually an Asset Purchase Agreement, often 50 to 80 pages, that defines exactly which assets transfer, the price, the representations and warranties, indemnification, the holdback, and the seller’s post-closing obligations.

Unlike the LOI, nearly every word of it is binding.

What is the difference between the LOI and the purchase agreement?

The letter of intent is the short, largely non-binding term sheet that sets the headline price and structure, with usually just one binding clause, a 60 to 90 day exclusivity or no-shop. The purchase agreement is the long, fully binding definitive contract that follows it.

The LOI says what the deal is in principle; the purchase agreement is the deal, with the detailed legal mechanics that actually transfer the practice.

What are representations and warranties in a veterinary practice sale?

Representations and warranties are factual statements each party makes and stands behind in the purchase agreement. In a typical middle-market deal the seller makes roughly 25 to 40 of them, covering items such as the accuracy of the financial statements, legal and licensing compliance, and the absence of undisclosed litigation, versus only about 5 made by the buyer.

If a seller rep proves false after closing, the buyer’s remedy is indemnification.

What is indemnification in a veterinary practice purchase agreement?

Indemnification is the provision that reimburses a party for losses from the other party’s breach of a representation, warranty, or covenant. It makes the buyer financially whole after a seller breach and is effectively a prerequisite for any buyer to sign.

It is limited by a basket, a threshold of losses the buyer must exceed before claiming, and a cap, a ceiling on total seller liability, though fraud and fundamental reps usually fall outside the cap.

How long do the seller’s reps survive after closing?

The survival period for general, non-fundamental reps commonly runs 12 to 24 months after closing, and a 2025 industry study found the median survival period returned to 12 months. Fundamental reps such as title, authority, and taxes, along with fraud, survive far longer.

In deals backed by reps and warranties insurance, an increasing share of agreements have the general reps not survive closing at all, with the insurer carrying the risk instead.

What is a holdback in a veterinary practice sale?

A holdback is a portion of the purchase price the buyer holds back at closing and pays later, instead of paying it in full to the seller. In veterinary practice sales it commonly runs 10 to 15 percent of the price and secures seller breaches of reps and warranties, working-capital true-ups, identified known risks, and earn-outs, with the balance released at the end of the survival period if no covered claim arises.

In larger M&A, dedicated indemnification holdbacks have actually declined as reps and warranties insurance takes over, but a seller holdback remains the standard tool in smaller, traditional practice sales.

What is a working-capital adjustment?

A working-capital adjustment trues up the price to an agreed net-working-capital peg, a normalized average target set during financial due diligence. If actual working capital at closing is above the peg, the buyer pays the seller the surplus; if it falls short, the seller pays or it is drawn from the holdback.

The true-up is typically calculated 60 to 90 days after closing, so the final dollar figure is not known on closing day.

Do I still need a non-compete after the FTC ban was vacated?

The FTC’s 2024 rule banning most non-competes never took effect, a court blocked it in August 2024, and the FTC formally voted to vacate it in September 2025, returning enforceability to state law case by case. Critically, the sale-of-business exception always remained intact, so a buyer can still require a selling veterinary owner to sign a non-compete and non-solicitation as part of the deal.

State law still governs scope and duration, so this belongs with your deal counsel.

---

Sources

Veterinary practice M&A and legal process

1. Mahan Law. “Letter of Intent: Binding or Non-Binding?” mahanlaw.com
2. Mahan Law. “Assumed Assets v. Assumed Liabilities.” mahanlaw.com
3. Mahan Law. “Purchase Price Holdbacks.” mahanlaw.com
4. Mahan Law. “Post-Closing Obligations.” mahanlaw.com
5. DMcounsel. “The Complete Legal Checklist for Selling a Veterinary Practice.” dmcounsel.com

Representations, warranties, and indemnification

6. Acquisition Stars. “Representations and Warranties in M&A.” acquisitionstars.com
7. National Law Review / Chuhak & Tecson. “Overview of Representations, Warranties and Indemnification in M&A.” natlawreview.com
8. Wyrick Robbins Yates & Ponton LLP. “Indemnification Caps and Baskets in Private Company M&A Transactions: What’s Market?” wyrick.com

M&A deal-terms studies and market data

9. ABA. “2025 Private Target Mergers & Acquisitions Deal Points Study.” Business Law Today. businesslawtoday.org
10. American Bar Association. “ABA 2025 Private Target Mergers & Acquisitions Deal Points Study.” americanbar.org
11. SRS Acquiom. “M&A Deal Terms Study (2025).” srsacquiom.com
12. Prairie Capital Advisors. “Net Working Capital Adjustments in M&A Deals.” prairiecap.com
13. Ice Miller LLP. “Reps and Warranties Insurance Market Trends Cheat Sheet.” icemiller.com

Regulatory

14. American Veterinary Medical Association. “FTC Vacates Noncompete Rule, Shifts to Case-by-Case Enforcement.” avma.org